Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDraganfly Investments Regulatory News (DRG)

  • There is currently no data for DRG

Interim Results

30 Jan 2015 13:48

RNS Number : 6374D
Draganfly Investments Ltd
30 January 2015
 



Draganfly Investments Limited

 

("Draganfly" or the "Company")

 

Interim Results for period from May 1st 2013 to October 31st 2013

 

 

Chairman's Statement

 

Following the six months to the 31st October 2014, as disclosed in note 1 to these interim results, a placing took place on the 27th November. This was a success and the Company has raised gross placing proceeds of £360,000 from new investors. The additional funding has provided Draganfly with liquidity and scope to develop any investment opportunities that may arise in the coming months.

 

The net asset value of these interim results is per the pre consolidation shares and does include the Atlantic Healthcare PLC asset, and does not include the net placing proceeds.

As resolved at the shareholders meeting in November the unquoted shareholding in Atlantic Healthcare PLC is currently being distributed to the qualifying shareholders, being those that held shares in Draganfly on the 12th November 2014. Those investors that have bought shares in Draganfly after this date will not be entitled to the distribution.

 

We hope to be in a position to update the shareholders further at the financial year end of the company.

 

 

Edward Bayman

 

Chairman

 

T Edward G Bayman

+44 (0) 1534 787898

Dennis Edmonds

+44 (0) 7796 338 372

Ed Frisby/James Thompson

FinnCap (Nominated Adviser)

+44 (0)20 7220 0500

 

 

Unaudited Profit and loss account

for the period ended 31 October 2014

 

 

 

Continuing Operations

6 months to 31/10/14

6 months to 31/10/13

Notes

£

£

Turnover

2

88

(18,726)

Administrative expenses

(41,113)

(46,956)

Operating (loss)

(41,025)

(65,682)

Other interest receivable and similar income

 

1

 

2

Interest payable and similar charges

 

-

 

-

(Loss) on ordinary activities

(41,024)

(65,680)

There are no recognised gains or losses other than those included in the profit and loss account.

(Loss) per share - basic

Basic (in pence)

(0.03)p

(0.05)p

 

 

Unaudited Balance sheet

as at 31 October 2014

 

 

31/10/14

31/10/13

Notes

£

£

£

£

Current assets

Debtors

3,311

2,902

Investments

3

696,125

716,025

Cash accounts

36,653

55,432

736,089

774,359

Creditors: amounts falling due within one year

Creditors

4

(81,395)

(17,950)

Net assets

654,694

756,409

Capital and reserves

Called up share capital

1,256,270

1,256,270

Share premium account

1,980,303

1,980,303

Profit and loss account

(2,581,879)

(2,480,164)

Equity shareholders' funds

5

654,694

756,409

 

Unaudited Cash flow statement

for the period ended 31 October 2014

 

Period ended 31/10/14

Period ended 31/10/13

£

£

Reconciliation of operating loss to net

cash outflow from operating activities

Operating (loss)

(41,024)

(65,680)

Realised (gain) on sale of investments

-

(22,920)

Unrealised (gain) /loss on revaluation of investments

(88)

41,646

Decrease in debtors

5,547

2,505

Increase /(decrease) in general creditors

65,719

(14,974)

Net cash flow from operating activities

30,154

(59,423)

Cash flow statement

Net cash flow from operating activities

30,154

(59,423)

Capital expenditure and financial investment

-

104,685

Increase in cash in the period

30,154

45,262

Increase in cash in the period

30,154

45,262

Opening cash balance

6,499

10,170

Closing cash balance

36,653

55,432

 

 

Notes to the interim statements

for the period ended 31 October 2014

 

 

1 Accounting policies

Basis of preparation

The financial statements are prepared in accordance with applicable UK accounting standards.

Going concern basis of accounting

As at the period end date the company was dependent on realisation of sufficient cash from its unquoted investments or raising new funds to be able to meet its operating expenses.

 

In November 2014 it was resolved to restructure the company in order to raise additional capital by way of a share subscription. It was proposed that prior to the subscription, the company's holding in Atlantic Healthcare would be distributed in specie on a pro rata basis to the existing shareholders and at the same time an additional £400,000 would be raised by subscriptions, at a valuation of the company of £600,000 (including the subscriptions but excluding the shareholding in Atlantic Healthcare). The final irrevocable subscriptions received came to £360,000.

 

As a result the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for a minimum period of at least 12 months from the date of approval of the financial statements. Thus they continue to adopt the going concern basis of accounting in preparing the financial statements.

 

Investments

In accordance with FRS 26, investments are designated as at fair value through profit or loss.

Quoted investments are stated at mid-market prices at the balance sheet date.

Unlisted investments are stated at 'price of recent investment', reflecting the early stage nature of the investment. The following considerations are used when calculating the 'price of recent investment'

(i) Where the investment being valued was itself made recently, its cost will generally provide a good indication of fair value.

(ii) Where there has been a recent investment by third parties, the price of that investment will provide a basis of the valuation.

Where a fair value cannot be estimated reliably, the investment is reported at cost or the carrying value at the previous reporting date, unless there is evidence that the investment has since been impaired.

Taxation

The company has been granted exempt company status within the meaning of Article 123A of the Income Tax (Jersey) Law 1961 (as amended). The effect of such special status is that the company is treated as a non-resident company for the purposes of Jersey tax laws and is therefore exempt from Jersey income tax on its profits arising outside Jersey and, by concession, on bank deposit interest arising in Jersey (and from any obligation to withhold Jersey income tax from any interest or dividend payments made by it). This status is renewable on an annual basis upon payment of a fee to the Comptroller of Income Tax in Jersey, and it is the company's intention to maintain this status.

Consequently, no provision for taxation, either current or deferred has been made in these financial statements.

 

2 Turnover

Turnover is derived from its principal activity and includes dividends received from investments. It also includes realised and unrealised profits and losses on investments.

 

3 Investments

 

The carrying value of investments is stated as follows:

 

Quoted

£

Unquoted

£

Total

£

Fair value of investments at 1 May 2014

16,818

679,219

696,037

Costs of investment purchases in the period

-

-

-

Sale proceeds of investments sold in the period

-

-

-

16,818

679,219

696,037

Realised gains on sale of investments included in the profit and loss account

-

-

-

Unrealised change in fair value of investments held at 31 October 2014 included in the profit and loss account

88

-

88

88

-

88

Fair value of total investments at 31 October 2014

16,906

679,219

696,125

4 Creditors: amounts falling due within one year

 

31/10/2014

£

31/10/2013

£

Other creditors

81,395

17,950

81,395

17,950

 

5 Reconciliation of Shareholders' funds

 

 

Profit and Loss Account

£

Called up Share Capital

£

Share Premium

Account

£

Total

£

As at 1st May 2014

(2,540,855)

1,256,270

1,980,303

695,718

(Loss) for the period

(41,024)

-

-

(41,024)

As at 31st October 2014

(2,581,879)

1,256,270

1,980,303

654,694

 

6 Earnings per share

Basic earnings per share is calculated on the basis of the (loss) for the period of £39,868 and 125,627,000 shares being the weighted average number of shares in issue during the trading period and is stated in pence.

7 Dividends

No dividends have been paid or proposed.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IR XBLFXEFFZBBE
Date   Source Headline
17th Apr 20124:06 pmRNSNet Asset Value(s)
9th Mar 20127:00 amRNSNet Asset Value(s)
8th Feb 201212:09 pmRNSNet Asset Value(s)
30th Jan 201210:21 amRNSHalf Yearly Report
4th Jan 20129:58 amRNSNet Asset Value(s)
14th Dec 20117:00 amRNSHolding(s) in Company
5th Dec 20113:36 pmRNSNet Asset Value(s)
28th Nov 20114:31 pmRNSIssue of Equity
10th Nov 20114:35 pmRNSNet Asset Value(s)
11th Oct 201110:46 amRNSNet Asset Value(s)
7th Sep 20118:48 amRNSNet Asset Value(s)
30th Aug 20113:28 pmRNSDealing by investment manager
26th Aug 20111:35 pmRNSResult of AGM
25th Aug 20115:44 pmRNSDealing by investment manager
4th Aug 20112:41 pmRNSNet Asset Value(s)
3rd Aug 20117:00 amRNSFinal Results
5th Jul 20113:20 pmRNSNet Asset Value(s)
16th Jun 201110:24 amRNSNet Asset Value(s)
4th May 201111:50 amRNSNet Asset Value(s)
12th Apr 201111:34 amRNSNet Asset Value(s)
7th Mar 20117:00 amRNSNet Asset Value(s)
2nd Feb 201111:59 amRNSNet Asset Value(s)
20th Jan 20117:00 amRNSHalf Yearly Report
6th Jan 20112:15 pmRNSNet Asset Value(s)
7th Dec 201010:00 amRNSIncrease in Share Price
3rd Dec 20104:34 pmRNSNet Asset Value(s)
14th Oct 20102:01 pmRNSNet Asset Value
14th Oct 20101:59 pmRNSAGM Statement
17th Sep 20107:00 amRNSFinal Results
6th Sep 20101:27 pmRNSStmnt re Share Price Movement
2nd Sep 20104:33 pmRNSNet Asset Value(s)
17th Aug 20103:40 pmRNSNet Asset Value(s)
27th Jul 201011:18 amRNSNet Asset Value(s)
16th Jun 201010:13 amRNSNet Asset Value(s)
21st May 20105:27 pmRNSNet Asset Value(s)
21st Apr 20108:40 amRNSNet Asset Value(s)
22nd Mar 201011:31 amRNSNet Asset Value(s)
15th Feb 20107:00 amRNSNet Asset Value(s)
22nd Dec 200911:21 amRNSHalf Yearly Report
11th Dec 20097:00 amRNSNet Asset Value(s)
6th Nov 20097:00 amRNSNet Asset Value(s)
15th Oct 200911:58 amRNSNet Asset Value(s)
6th Oct 200911:06 amRNSHolding(s) in Company
14th Sep 20097:00 amRNSAmendment re net asset value
10th Sep 200911:57 amRNSNet Asset Value(s)
19th Aug 20091:49 pmRNSResult of AGM
11th Aug 20097:00 amRNSNet Asset Value(s)
29th Jul 20095:14 pmRNSFinal Results
15th Jul 20095:01 pmRNSNet Asset Value(s)
8th Jun 20098:23 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.